Figure 2From: Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunctionIncorporation of PPI-1038 (100 μM; 72 hr) into the 16:0/22:6, 18:0/22:6 and 18:1/22:6 plasmalogens of 158N and 158JP oligodendrocytes. N = 5. P = [13C16]palmitic acid; G = [13C3]glycerol; D = [13C3]DHA.Back to article page